Subscribe to our Newsletter and stay updated
SPCC kick-starts 2022 by showcasing a new, stronger and revamped identity.
The pandemic has revolutionised our relationship with technology over the last two years, leading to greater interaction between the real world and the digital world.
In these new circumstances, we at SPCC decided to switch to working entirely online. Although this strategic decision called for a new organisational structure, it meant that we could reach more people all over the world, in an increasingly inclusive manner.
At SPCC, we have always believed in innovation, research and scientific progress, since day one. But above all, we believe that sharing new knowledge and best practices in the Cancer Care Continuum field is essential in order to improve cancer prevention, diagnosis, treatment and research pathways.
Our new visual identity is the result of all this: our values, and the purpose, mission and vision of SPCC. We aim to be the global point of reference for a community that shares the common goal of taking on cancer to the best of our ability.
Our new look showcases an inclusive, innovative and digital SPCC that is able to evolve while maintaining a solid identity and ensuring an independent and transparent offering. The new logo preserves continuity with the more than twenty years of history of SPCC, while marking a clear break from the past. We have kept the shape and colours of the brand, which represent the three forms of collaboration with our supporters, while the ribbons, symbolising cancer care, have been untied, with considerable momentum towards the future and continuous growth.
Sharing Progress in Cancer Care is a knowledge tool for a world that can deliver better quality of care and life to us all.
Cancerworld publishes a new article and a news piece online each week on www.cancerworld.net.
Visit www.cancerworld.net to register for the fortnightly Cancerworld Newsletter and keep up to date with the latest news and articles. To receive a free printed copy, twice a year, subscribe via the website. Cancerworld is distributed at major conferences, and mailed to subscribers and European leaders.